Clinical TrialsSearch results
Number of results: 972
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Completed
- Drug-Drug interaction study of AJM300(1)
- Combination clinical pharmacology study of oral midazolam, oral prednisolone, oral atorvastatin and intravenous midazolam in healthy male subjects -
- Ulcerative Colitis
- Takeuchi Yutaka
- 2023-06-19
Completed
- ELEVATE UC 40 JAPAN: Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis in Japanese Subjects
- Ulcerative colitis
- IQVIA Services Japan K.K. ICCC:
- 2021-01-13
Completed
- Further maintenance of remission for a year after Qing-Dai withdrawal in ulcerative colitis treatment:randomized controlled trial
- Ulcerative colitis
- Kitazono Takanari
- 2019-03-22
Recruiting
- Evaluation of Oral Tofacitinib in Children Aged 2 to 17 Years Old Suffering From Moderate to Severe Ulcerative Colitis
- Ulcerative Colitis
- Kawai Norisuke
- 2021-10-07
Other
- ELEVATE UC OLE: An Open-Label Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis
- Ulcerative colitis
- Kawai Norisuke
- 2021-01-13
Other
- Establishment of surveillance system for the longstanding ulcerative colitis patients Comparative study of efficacy for the targeted biopsy and the step biopsy
- Ulcerative colitis
- Teikyo University School of Medicine
- 2009-01-05
Recruiting
- A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- Ulcerative Colitis Crohn's Disease
- Shikamura Mitsuhiro
- 2023-07-05
Recruiting
- Effect of empagliflozin for HFpEF with Type2 DM
- Type2 DM
- Shiose Akira
- 2019-03-29
Other
- Clinical study of combinational therapy of AD-4833 with metformin -Phase III double-blind comparative study-
- Type2 Diabetes
- Takeda Pharmaceutical Company Limited
- 2008-04-04
Other
- Post-marketing Clinical Trial of Pioglitazone - A Study of Preventive Effects on the Onset and Recurrence of Macrovascular Events -
- Type2 Diabetes
- Takeda Pharmaceutical Company Limited
- 2008-09-10